Clinical Features of Neurodevelopmental Outcomes in Children with Preterm Severe Fetal Growth Restriction: A Retrospective Observational Study.

developmental quotient fetal growth restriction neurodevelopment preterm birth small for gestational age

Journal

JMA journal
ISSN: 2433-3298
Titre abrégé: JMA J
Pays: Japan
ID NLM: 101769797

Informations de publication

Date de publication:
15 Jul 2022
Historique:
received: 24 02 2022
accepted: 26 04 2022
entrez: 22 8 2022
pubmed: 23 8 2022
medline: 23 8 2022
Statut: ppublish

Résumé

Fetal growth restriction (FGR) is a clinical condition wherein a fetus fails to achieve the expected growth potential. Although FGR is the leading cause of perinatal morbidity and mortality, there is a lack of knowledge about the long-term developmental outcomes of children who had FGR in Japan. Here, we sought to clarify the features of neurodevelopmental outcomes in preterm-born children with severe FGR (sFGR) and identify associated clinical factors. The clinical data of 26 preterm sFGR cases and 26 preterm appropriate for gestational age (AGA) cases with a similar gestational age distribution were reviewed retrospectively. Developmental quotient (DQ) scores assessed during the 1- and 2-year corrected ages using the Kyoto Scale of Psychological Development were analyzed. sFGR was diagnosed at 26 (18-34) weeks of gestation, and the gestational age at delivery was 31 (25-36) weeks. The overall DQ scores of children in the sFGR group were significantly lower than those in the AGA group (80 vs. 90.5, Our results indicate that preterm-born children with sFGR have greater neurodevelopmental impairment than preterm-born children without FGR, specifically in terms of the DQ scores for the Language-Social area. It is imperative to encourage continuous long-term follow-up and appropriate interventions after birth.

Identifiants

pubmed: 35992293
doi: 10.31662/jmaj.2022-0047
pmc: PMC9358274
doi:

Types de publication

Journal Article

Langues

eng

Pagination

341-348

Informations de copyright

Copyright © Japan Medical Association.

Déclaration de conflit d'intérêts

None

Références

JAMA Pediatr. 2020 Aug 1;174(8):772-781
pubmed: 32453414
Obstet Gynecol. 2002 Mar;99(3):490-6
pubmed: 11864679
Clin Exp Pediatr. 2021 Jul;64(7):313-321
pubmed: 33171036
Psychiatry Clin Neurosci. 2009 Apr;63(2):241-3
pubmed: 19335396
Brain Dev. 2016 Feb;38(2):188-95
pubmed: 26265090
Obstet Gynecol. 2021 Feb 1;137(2):e16-e28
pubmed: 33481528
Am J Obstet Gynecol. 2018 Feb;218(2S):S745-S761
pubmed: 29422210
Pediatr Int. 2008 Feb;50(1):23-8
pubmed: 18279200
BJOG. 2018 Jan;125(1):16-25
pubmed: 29024294
Am J Obstet Gynecol. 2011 Jan;204(1):34.e1-9
pubmed: 21056403
Am J Obstet Gynecol. 2009 Apr;200(4):409.e1-6
pubmed: 19217594
Indian Pediatr. 2020 Apr 15;57(4):296-300
pubmed: 32038037
BJOG. 2015 Jul;122(8):1062-72
pubmed: 25990812
Brain Dev. 2016 Apr;38(4):377-85
pubmed: 26542468
Am J Obstet Gynecol. 2011 Apr;204(4):288-300
pubmed: 21215383

Auteurs

Takahiro Motoki (T)

Department of Gynecology and Obstetrics, Kyoto University, Kyoto, Japan.

Yoshitsugu Chigusa (Y)

Department of Gynecology and Obstetrics, Kyoto University, Kyoto, Japan.

Seiichi Tomotaki (S)

Department of Pediatrics, Kyoto University, Kyoto, Japan.

Yosuke Kawamura (Y)

Department of Gynecology and Obstetrics, Kyoto University, Kyoto, Japan.

Mana Taki (M)

Department of Gynecology and Obstetrics, Kyoto University, Kyoto, Japan.

Ken Yamaguchi (K)

Department of Gynecology and Obstetrics, Kyoto University, Kyoto, Japan.

Masaki Mandai (M)

Department of Gynecology and Obstetrics, Kyoto University, Kyoto, Japan.

Haruta Mogami (H)

Department of Gynecology and Obstetrics, Kyoto University, Kyoto, Japan.

Classifications MeSH